IngentaConnect Magnesium supplementation and perinatal hypoxia: outcome of a par...

Abstract:

Objective

To determine the effects of magnesium supplementation in pregnancy on the incidence of hypoxic-ischaemic encephalopathy (HIE). Design

A randomised double-blind placebo-controlled study. Setting

A Midwife Obstetric Unit and its two referral hospitals in Cape Town, South Africa. Population

A group of 4494 black pregnant women of low socio-economic status. Method

Mothers, from the time of booking until delivery, were randomised to receive two identical tablets daily, containing either 128 mg slow-release magnesium stearate or lactose sugar. Main outcome measures

Primary: The incidence of HIE. Secondary: The incidence of fetal heart rate decelerations, term Stillbirths, Low Apgar Scores, Meconium Aspiration Pneumonia. Results

The incidence of HIE (0.9%) was considerably less than anticipated (2%). There were 22 infants in the placebo group and 15 infants in the supplemented group (P= 0.279). The difference was not significant.

Secondary outcomes such as late fetal heart rate decelerations (P= 0.002) and term stillbirths (P= 0.016) were reduced significantly in the supplemented group, but this finding needs further substantiation. Conclusions

Magnesium supplementation did not reduce the incidence of HIE significantly, probably because the study was underpowered and compliance was relatively poor.

Keywords: Hypoxia; magnesium; perinatal; pregnancybody

Document Type: Research article

DOI: 10.1111/j.1471-0528.2007.01409.x

Affiliations: 1: Department of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa 2: Biostatistics Unit, Medical Research Council of South Africa, Cape Town, South Africa

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax Refund Policy

Magnesium supplementation and perinatal hypoxia: outcome of a parallel group randomised trial in pregnancy